OR WAIT null SECS
August 24, 2022
Aerie to be purchased by Alcon after recently bringing two glaucoma drugs to market.
August 12, 2022
Merck, known as MSD outside of the United States and Canada, will collaborate with Cerevance to identify novel targets for Alzheimer’s disease.
August 10, 2022
Pfizer’s $5.4 billion acquisition of Global Blood Therapeutics is expected to strengthen its sickle cell disease portfolio.
Sartorius’ £415 million (US$429 million) acquisition of Albumedix is intended to bolster its portfolio with recombinant albumin-based solutions.
Sanofi and Innovent have entered into a strategic collaboration to accelerate development of oncology medicines and expand their presence in China.
August 09, 2022
Amgen’s acquisition of Chemocentryx includes the autoimmune disease drug Tavneos (avacopan).
August 05, 2022
La Jolla’s acquisition of Carterra’s LSA Platform is designed to advance their immunological and infectious disease research.
August 03, 2022
Ipsen and Marengo Therapeutics will collaborate to advance two precision immuno-oncology candidates.
August 02, 2022
GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.
July 26, 2022
Discovery Life Sciences’ acquisition of AllCells is intended to bolster its cell and gene therapy products and services.